Delimiting the boundaries of generalized anxiety disorder: differentiating high worriers with and without GAD

被引:94
作者
Ruscio, AM [1 ]
机构
[1] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA
关键词
worry; generalized anxiety disorder; diagnosis; measurement; symptoms; severity (disorders);
D O I
10.1016/S0887-6185(02)00130-5
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Investigations of the boundary between generalized anxiety disorder (GAD) and normal worry have relied primarily on comparisons of GAD-diagnosed individuals with non-anxious controls. One limitation of this approach has been its inability to determine whether characteristics associated with GAD are unique to the disorder or are typical of severe worry more generally. The present studies made this differentiation using a virtually unstudied population: severe worriers failing to meet the diagnostic criteria for GAD. These studies assessed the prevalence of non-GAD high worriers in several college samples and identified features distinguishing them from individuals with GAD. Non-GAD high worriers far outnumbered GAD high worriers and reported many of the same symptoms as their GAD-diagnosed counterparts. However, results revealed several characteristics that consistently distinguished the two groups. Implications for the conceptualization, assessment, and investigation of worry and GAD are discussed. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:377 / 400
页数:24
相关论文
共 38 条
[1]  
[Anonymous], 1994, WORRYING PERSPECTIVE
[2]  
[Anonymous], 1990, COMORBIDITY MOOD ANX
[3]  
BARLOW DH, 1986, AM J PSYCHIAT, V143, P40
[4]   PSYCHOMETRIC PROPERTIES OF THE BECK DEPRESSION INVENTORY - 25 YEARS OF EVALUATION [J].
BECK, AT ;
STEER, RA ;
GARBIN, MG .
CLINICAL PSYCHOLOGY REVIEW, 1988, 8 (01) :77-100
[5]  
Beck AT., 1979, Cognitive Therapy of Depression
[6]  
Borkovec T.D., 1994, Worrying: Perspectives on theory, assessment, and treatment, P5, DOI DOI 10.1017/S0033291700036357
[7]  
Borkovec TD., 1991, Chronic anxiety: Generalized anxiety disorder and mixed anxiety-depression, P29
[8]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[9]  
BRAWMANMINTZER O, 1993, AM J PSYCHIAT, V150, P1216
[10]   COMORBIDITY AMONG ANXIETY DISORDERS - IMPLICATIONS FOR TREATMENT AND DSM-IV [J].
BROWN, TA ;
BARLOW, DH .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1992, 60 (06) :835-844